These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38267835)

  • 21. Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis.
    Fox D; To TM; Seetasith A; Patel AM; Iannaccone ST
    Adv Ther; 2023 Mar; 40(3):903-919. PubMed ID: 36534265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective cohort study of children with spinal muscular atrophy type 2 receiving anesthesia for intrathecal administration of nusinersen.
    Bielsky AR; Fuhr PG; Parsons JA; Yaster M
    Paediatr Anaesth; 2018 Dec; 28(12):1105-1108. PubMed ID: 30284761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spinal cord atrophy associated with arachnoiditis as demonstrated by computed tomography.
    Donaldson I; Gibson R
    Neuroradiology; 1982; 24(2):101-5. PubMed ID: 7177369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anesthetic management of pediatric patients undergoing intrathecal nusinersen administration for treatment of spinal muscular atrophy: A single-center experience.
    Brollier LD; Matuszczak M; Marri T; Carbajal JG; Moorman AT; Sorial EM; Jain R
    Paediatr Anaesth; 2021 Feb; 31(2):160-166. PubMed ID: 32623818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Technique Using Magnetic Resonance Imaging in the Supine and Prone Positions for Diagnosing Lumbar Adhesive Arachnoiditis: A Preliminary Study.
    Tsuchida R; Sumitani M; Azuma K; Abe H; Hozumi J; Inoue R; Oshima Y; Katano S; Yamada Y
    Pain Pract; 2020 Jan; 20(1):34-43. PubMed ID: 31325409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibromyalgia and arachnoiditis presented as an acute spinal disorder.
    Idris Z; Ghazali FH; Abdullah JM
    Surg Neurol Int; 2014; 5():151. PubMed ID: 25396073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arachnoiditis Ossificans: A Rare Etiology of Oil-Based Spinal Myelography and Review of the Literature.
    Wang S; Ahuja CS; Das S
    World Neurosurg; 2019 Jun; 126():189-193. PubMed ID: 30862590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory markers in cerebrospinal fluid of paediatric spinal muscular atrophy patients receiving nusinersen treatment.
    Scheijmans FEV; Cuppen I; Zwartkruis MM; Signoria I; van Ekris C; Asselman F; Wadman RI; Knol EF; van der Pol WL; Groen EJN
    Eur J Paediatr Neurol; 2023 Jan; 42():34-41. PubMed ID: 36525882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid characteristics of patients treated with intrathecal nusinersen for spinal muscular atrophy.
    Orbach R; Sagi L; Sadot E; Tokatly Latzer I; Shtamler A; Zisberg T; Fattal-Valevski A
    Muscle Nerve; 2022 Dec; 66(6):762-766. PubMed ID: 36214191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subarachnoid-subarachnoid bypass for spinal adhesive arachnoiditis.
    Tachibana T; Moriyama T; Maruo K; Inoue S; Arizumi F; Yoshiya S
    J Neurosurg Spine; 2014 Nov; 21(5):817-20. PubMed ID: 25170651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients.
    Wurster CD; Winter B; Wollinsky K; Ludolph AC; Uzelac Z; Witzel S; Schocke M; Schneider R; Kocak T
    J Neurol; 2019 Jan; 266(1):183-194. PubMed ID: 30460449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adhesive arachnoiditis in mixed connective tissue disease: a rare neurological manifestation.
    Khan MU; Devlin JA; Fraser A
    BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 27986694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforaminal intrathecal delivery of nusinersen for older children and adults with spinal muscular atrophy and complex spinal anatomy: an analysis of 200 consecutive injections.
    Weaver JJ; Hallam DK; Chick JFB; Vaidya S; Shin DS; Natarajan N; Rad N; Reis J; Koo KSH; Shivaram GM; Thibodeau A; Apkon S; Monroe EJ
    J Neurointerv Surg; 2021 Jan; 13(1):75-78. PubMed ID: 32471828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrathecal hyaluronidase treatment of chronic spinal arachnoiditis of noninfective etiology.
    Gourie-Devi M; Satish P
    Surg Neurol; 1984 Sep; 22(3):231-4. PubMed ID: 6547785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults.
    Panackal AA; Komori M; Kosa P; Khan O; Hammoud DA; Rosen LB; Browne SK; Lin YC; Romm E; Ramaprasad C; Fries BC; Bennett JE; Bielekova B; Williamson PR
    Clin Infect Dis; 2017 Feb; 64(3):275-283. PubMed ID: 28011613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity.
    Nakao S; Yamada S; Tsuda K; Yokomizo T; Sato T; Tanoue S; Hiraki T
    JA Clin Rep; 2020 Apr; 6(1):28. PubMed ID: 32314319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: Transforaminal versus conventional approach.
    Bortolani S; Stura G; Ventilii G; Vercelli L; Rolle E; Ricci F; Bergui M; Mongini T
    Neuromuscul Disord; 2019 Oct; 29(10):742-746. PubMed ID: 31604650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed symptomatic spinal adhesive arachnoiditis after surgery for thoracolumbar flexion-distraction injury: A case report.
    Lim DJ; Sohn JM
    Int J Surg Case Rep; 2020; 74():273-276. PubMed ID: 32916383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of radionuclide myelography in the evaluation of spinal arachnoiditis.
    Lee KF; Park CH; Schnapf D; Martinez L; Thompson NL; Tatu W
    Neuroradiology; 1978; 16():359-61. PubMed ID: 745714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience.
    Haché M; Swoboda KJ; Sethna N; Farrow-Gillespie A; Khandji A; Xia S; Bishop KM
    J Child Neurol; 2016 Jun; 31(7):899-906. PubMed ID: 26823478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.